← Leaderboards
Deok-Ho Kim
University Of Washington
$16,008,573
Attributed
$22,054,615
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,054,615 · 14
By mechanism
R01$13,224,270 · 7
UH3$4,399,478 · 2
UG3$3,125,502 · 2
R21$1,305,365 · 3
Top collaborators
- Chulan Kwon13 shared
- David Alan Kass5 shared
- Eun Hyun Ahn2 shared
- Esak Lee2 shared
- Gabsang Lee2 shared
- Morayma Reyes1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Edward J Kelly$2,869,393
- Albert Folch$14,713,839
- Florence Sheehan$2,956,077
- Eun Hyun Ahn$813,589
- Nisa P Williams$32,888
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPhenotypeTissuesIn VitroStructureMolecularCardiac MyocytesIn VivoPhysiologicalGenesCardiacEngineeringBase3-DimensionalTissue EngineeringInduced Pluripotent Stem CellPre-ClinicalElectrophysiology (Science)Human ModelHeartNovel TherapeuticsFunctional DisorderPropertyPharmaceutical Preparations
Grant awards (51)
Microphysiological Model of Human Cardiac Sympathetic Innervation$694,482
R01 · FY2025 · HL · contact PI
High-throughput neurovascular-unit-on-a-chip with OASIS for modeling Parkinson's disease$581,422
R01 · FY2025 · NS · contact PI
Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents$425,935
R01 · FY2025 · CA
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$776,816
UH3 · FY2024 · TR · contact PI
Microphysiological Model of Human Cardiac Sympathetic Innervation$690,903
R01 · FY2024 · HL · contact PI
High-throughput neurovascular-unit-on-a-chip with OASIS for modeling Parkinson's disease$590,144
R01 · FY2024 · NS · contact PI
Transcriptomic Entropy to Quantify Maturation of PSC-Derived Cardiomyocytes$558,394
R01 · FY2024 · HL
Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents$443,191
R01 · FY2024 · CA
High-throughput nanoIEA-based Assay for Screening Immune Cell-Vascular Interactions$237,913
R21 · FY2024 · AI
Microphysiological Model of Human Cardiac Sympathetic Innervation$74,154
R01 · FY2024 · HL · contact PI
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$789,923
UH3 · FY2023 · TR · contact PI
Microphysiological Model of Human Cardiac Sympathetic Innervation$715,555
R01 · FY2023 · HL · contact PI
Transcriptomic Entropy to Quantify Maturation of PSC-Derived Cardiomyocytes$569,791
R01 · FY2023 · HL
High-throughput nanoIEA-based Assay for Screening Immune Cell-Vascular Interactions$211,654
R21 · FY2023 · AI
Microphysiological Model of Human Cardiac Sympathetic Innervation$75,437
R01 · FY2023 · HL · contact PI
Microphysiological Model of Human Cardiac Sympathetic Innervation$74,154
R01 · FY2023 · HL · contact PI
Microphysiological Model of Human Cardiac Sympathetic Innervation$54,173
R01 · FY2023 · HL · contact PI
Microphysiological Model of Human Cardiac Sympathetic Innervation$44,348
R01 · FY2023 · HL · contact PI
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$810,112
UH3 · FY2022 · TR · contact PI
Microphysiological Model of Human Cardiac Sympathetic Innervation$741,815
R01 · FY2022 · HL · contact PI
Transcriptomic Entropy to Quantify Maturation of PSC-Derived Cardiomyocytes$569,789
R01 · FY2022 · HL
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY$531,704
R01 · FY2022 · HL · contact PI
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity$326,693
UH3 · FY2022 · TR · contact PI
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$807,541
UG3 · FY2021 · TR · contact PI
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity$757,735
UH3 · FY2021 · TR · contact PI
Transcriptomic Entropy to Quantify Maturation of PSC-Derived Cardiomyocytes$569,789
R01 · FY2021 · HL
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY$531,704
R01 · FY2021 · HL · contact PI
A NANOPATTERNED MEA-BASED FUNCTIONAL PHENOTYPING ASSAY FOR DRUG-INDUCED CARDIOTOXICITY SCREENING$375,358
R01 · FY2021 · HL · contact PI
TISSUE ENGINEERED HUMAN NEUROMUSCULAR JUNCTIONS FOR MODELING AXONAL NEUROPATHY$356,426
R01 · FY2021 · NS · contact PI
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity$80,419
UH3 · FY2021 · TR · contact PI
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity$57,922
UH3 · FY2021 · TR · contact PI
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity$799,858
UH3 · FY2020 · TR · contact PI
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$793,250
UG3 · FY2020 · TR · contact PI
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY$520,924
R01 · FY2020 · HL · contact PI
A NANOPATTERNED MEA-BASED FUNCTIONAL PHENOTYPING ASSAY FOR DRUG-INDUCED CARDIOTOXICITY SCREENING$377,161
R01 · FY2020 · HL · contact PI
TISSUE ENGINEERED HUMAN NEUROMUSCULAR JUNCTIONS FOR MODELING AXONAL NEUROPATHY$178,012
R01 · FY2020 · NS · contact PI
Tissue Engineered Human Neuromuscular Junctions for Modeling Axonal Neuropathy$154,533
R01 · FY2020 · NS · contact PI
Disease Modeling and Phenotypic Drug Screening for Dystrophic Cardiomyopathy$574,972
R01 · FY2019 · HL · contact PI
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity$421,521
UG3 · FY2019 · EB · contact PI
A Nanopatterned MEA-based Functional Phenotyping Assay for Drug-Induced Cardiotoxicity Screening$378,845
R01 · FY2019 · HL · contact PI
Tissue Engineered Human Neuromuscular Junctions for Modeling Axonal Neuropathy$332,048
R01 · FY2019 · NS · contact PI
A HUMAN IPSC-BASED 3D MICROPHYSIOLOGICAL SYSTEM FOR MODELING CARDIAC DYSFUNCTION IN MICROGRAVITY$313,475
UG3 · FY2019 · EB · contact PI
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity$789,715
UG3 · FY2018 · EB · contact PI
A Nanopatterned MEA-based Functional Phenotyping Assay for Drug-Induced Cardiotoxicity Screening$379,709
R01 · FY2018 · HL · contact PI
Tissue Engineered Human Neuromuscular Junctions for Modeling Axonal Neuropathy$331,800
R01 · FY2018 · NS · contact PI
A Nanopatterned MEA-based Functional Phenotyping Assay for Drug-Induced Cardiotoxicity Screening$380,310
R01 · FY2017 · HL · contact PI
Tissue Engineered Human Neuromuscular Junctions for Modeling Axonal Neuropathy$347,288
R01 · FY2017 · NS · contact PI
Injectable myocardial matrix-grapheme composite hydrogels for functional cardiac tissue engineering$207,232
R21 · FY2017 · EB · contact PI
Injectable myocardial matrix-grapheme composite hydrogels for functional cardiac tissue engineering$227,486
R21 · FY2016 · EB · contact PI
Nanopatterned 3D Vascularized Functional Muscle Patch$229,680
R21 · FY2015 · AR · contact PI
Nanopatterned 3D Vascularized Functional Muscle Patch$191,400
R21 · FY2014 · AR · contact PI